Sigilon Therapeutics, Inc.

CIK 1821323 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Sigilon Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Feb 14, 2024SC 13G/A0001193125-24-036373
Aug 21, 202315-12G0001193125-23-216622
Aug 15, 202340000899243-23-018154
Aug 15, 2023EFFECT9999999995-23-002390
Aug 14, 2023SC 13D/A0001193125-23-212400
Aug 14, 202340000899243-23-018115
Aug 11, 2023POS AM0001193125-23-210776
Aug 11, 202340001415889-23-012134
Aug 11, 2023S-8 POS0001193125-23-210782
Aug 11, 202340001415889-23-012128
Aug 11, 202340001415889-23-012136
Aug 11, 202340001415889-23-012126
Aug 11, 202340001415889-23-012130
Aug 11, 202325-NSE0001354457-23-000574
Aug 11, 202340001415889-23-012127
Aug 11, 2023S-8 POS0001193125-23-210785
Aug 11, 202340001415889-23-012133
Aug 11, 20238-K0001193125-23-210739
Aug 11, 2023S-8 POS0001193125-23-210791
Aug 11, 202340001415889-23-012129
Aug 11, 202340001415889-23-012132
Aug 11, 2023S-8 POS0001193125-23-210799
Aug 11, 202340001415889-23-012135
Aug 11, 202340001415889-23-012131
Aug 10, 2023SC 14D9/A0001193125-23-208190